Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision label v3.4.2 was added and the previous v3.4.1 label was removed, indicating a versioning update rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:46:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-04T23:34:29.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The changes are minor: an addition of a 'Show glossary' option and several metadata/date updates, which do not affect core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-01-28T19:59:05.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears in the Study Documents section, replacing the previous v3.3.3 entry. This is a minor metadata update to the document versions listed on the page.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:03.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing Florida and Georgia, and removed the separate Florida Locations and Georgia Locations blocks. Revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:21:28.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled from PubMed and may not be about the study; updated revision to v3.3.2. Removed the previous wording stating that publications come from PubMed and are automatically created by ClinicalTrials.gov Identifier (NCT Number) and the older revision reference v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:56:18.000Z thumbnail image

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.